低分化前列腺癌化疗后葡萄糖代谢改变先于PSMA表达变化
一例73岁男性低分化前列腺癌患者,分期FDG PET/CT显示胃、前列腺内、淋巴结及广泛骨病变,前列腺特异性抗原大于1000。化疗后18F-PSMA-1007 PET/CT显示与分期FDG PET/CT表现相似的广泛病变,提示无明显治疗反应;FDG PET/CT显示部分代谢缓解,与前列腺特异性抗原水平改善相关。本例提示低分化前列腺癌化疗诱导的葡萄糖代谢改变可能先于PSMA表达变化。
要点
- 低分化前列腺癌化疗后FDG PET/CT可显示部分代谢缓解而PSMA PET/CT无明显治疗反应。
- 葡萄糖代谢改变可能先于PSMA表达变化。
- 前列腺特异性抗原水平改善与FDG代谢缓解相关。
核心结论
- 本例提示低分化前列腺癌化疗诱导的葡萄糖代谢改变可能先于PSMA表达变化。
研究设计与样本
- 本文为73岁男性低分化前列腺癌病例报告,经胃镜活检证实为低分化癌。
主要发现
- 分期FDG PET/CT显示胃、前列腺内、淋巴结及广泛骨病变,前列腺特异性抗原水平大于1000。
- 化疗后18F-PSMA-1007 PET/CT显示与分期FDG PET/CT表现相似的广泛病变,提示无明显治疗反应。
- 化疗后FDG PET/CT显示部分代谢缓解,与前列腺特异性抗原水平改善相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 73-year-old man presented with gastric lesion on upper endoscopy, biopsy-proven as poorly differentiated carcinoma. Staging FDG PET/CT scan showed gastric, intraprostatic, nodal, and extensive osseous lesions. Prostate-specific antigen levels were greater than 1000. The patient was treated as metastatic poorly differentiated prostate cancer with chemotherapy. Posttherapy 18 F-PSMA-1007 and FDG PET/CT scans were obtained. PSMA PET/CT scan revealed extensive disease similar in appearance as staging FDG PET/CT scan, indicating no apparent treatment response. FDG PET/CT scan showed partial metabolic response, correlating with improved prostate-specific antigen levels. This case indicates that chemotherapy-induced changes in glucose metabolism likely precede change in PSMA expression in poorly differentiated prostate cancer.
引用
- Alabed YZ. Altered Glucose Metabolism Postchemotherapy Precedes PSMA Expression in Poorly Differentiated Prostate Cancer. Clin Nucl Med. 2022. PMID: 36368043. doi:10.1097/RLU.0000000000004440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。